Cargando…

RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) represents the fourth leading cause of cancer-related death in the world. Sorafenib, a first-line chemotherapeutic drug that inhibits cell growth and angiogenesis, has become the standard therapy for inoperable advanced HCC. However, while sorafenib imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xing, Lu, Cheng, Liu, Ziyu, Lin, Yan, Huang, Julu, Lu, Lu, Li, Shuanghang, Huang, Xi, Tang, Minchao, Huang, Shilin, He, Ziqin, She, Xiaomin, Liang, Rong, Ye, Jiazhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252096/ https://www.ncbi.nlm.nih.gov/pubmed/37296859 http://dx.doi.org/10.3390/cancers15112897

Ejemplares similares

A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma
por: Huang, Julu, et al.
Publicado: (2023)

Eukaryotic Initiation Factor 4A-3: A Review of Its Physiological Role and Involvement in Oncogenesis
por: Ye, Jiazhou, et al.
Publicado: (2021)

Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma
por: Lin, Yan, et al.
Publicado: (2022)

RNA-Binding Motif Protein 38 as a Potential Biomarker and Therapeutic Target in Cancer
por: She, Xiaomin, et al.
Publicado: (2020)

Association of LncRNA‐GAS5 gene polymorphisms and PBMC LncRNA‐GAS5 level with risk of systemic lupus erythematosus in Chinese population
por: Liu, Chun‐Hong, et al.
Publicado: (2021)

Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer
por: Lin, Yan, et al.
Publicado: (2020)

LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Deng, Biyong, et al.
Publicado: (2021)

Progress of research on molecular targeted therapies for colorectal cancer
por: Huang, Shilin, et al.
Publicado: (2023)

LncRNA GAS8‐AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation
por: Wu, Xiaoming, et al.
Publicado: (2021)

LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis
por: Zhang, Xiaozhou, et al.
Publicado: (2022)

RBM10 regulates alternative splicing of lncRNA Neat1 to inhibit the invasion and metastasis of NSCLC
por: Cong, Shan, et al.
Publicado: (2022)

LncRNA FOXD2‐AS1 as a competitive endogenous RNA against miR‐150‐5p reverses resistance to sorafenib in hepatocellular carcinoma
por: Sui, Chengjun, et al.
Publicado: (2019)

Knockdown of lncRNA TP53TG1 Enhances the Efficacy of Sorafenib in Human Hepatocellular Carcinoma Cells
por: Lu, Qingchun, et al.
Publicado: (2022)

Alternative Splicing of Cdh23 Exon 68 Is Regulated by RBM24, RBM38, and PTBP1
por: Li, Nana, et al.
Publicado: (2020)

RBM47 restrains renal cell carcinoma progression and chemoresistance through interacting with lncRNA HOXB-AS1
por: Su, Qingfu, et al.
Publicado: (2023)

RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma
por: Ye, Jiazhou, et al.
Publicado: (2018)

Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma
por: Liang, Rong, et al.
Publicado: (2021)

LncRNA CRNDE Promotes ATG4B-Mediated Autophagy and Alleviates the Sensitivity of Sorafenib in Hepatocellular Carcinoma Cells
por: Chen, Lingxi, et al.
Publicado: (2021)

Genetic variation of lncRNA GAS5 contributes to the development of lung cancer
por: Li, Weihao, et al.
Publicado: (2017)

The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination
por: Xia, Anliang, et al.
Publicado: (2023)

Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma
por: Tao, Haisu, et al.
Publicado: (2022)

LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells: LIMT contributes to sorafenib chemoresistance in HCC
por: Sun, Jing, et al.
Publicado: (2021)

Genetic Variants of lncRNA GAS5 Are Associated with the Clinicopathologic Development of Oral Cancer
por: Hsieh, Ming-Hong, et al.
Publicado: (2021)

LncRNA GAS5 positively regulates IL‐10 expression in patients with generalized myasthenia gravis
por: Peng, Shuangshuang, et al.
Publicado: (2021)

PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38
por: Zhang, Min, et al.
Publicado: (2015)

Hypoxia-induced lncRNA RBM5-AS1 promotes tumorigenesis via activating Wnt/β-catenin signaling in breast cancer
por: Li, Xinping, et al.
Publicado: (2022)

LncRNA GAS5 inhibits Invasion and Migration of Lung Cancer through influencing EMT process
por: Zhu, Lihuan, et al.
Publicado: (2021)

The Rbm38-p63 Feedback Loop Is Critical for Tumor Suppression and Longevity
por: Jiang, Yuqian, et al.
Publicado: (2018)

The role of c-Myc-RBM38 loop in the growth suppression in breast cancer
por: Li, Xiao-Xia, et al.
Publicado: (2017)

Analysis of PANoptosis-Related LncRNA-miRNA-mRNA Network Reveals LncRNA SNHG7 Involved in Chemo-Resistance in Colon Adenocarcinoma
por: Huang, Jingjing, et al.
Publicado: (2022)

lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion
por: Zha, Zhuqing, et al.
Publicado: (2020)

Biological Function of Long Non-coding RNA (LncRNA) Xist
por: Wang, Wenlun, et al.
Publicado: (2021)

An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells
por: Tang, Shuyao, et al.
Publicado: (2016)

LncRNA HOTAIR Contributes to Sorafenib Resistance through Suppressing miR-217 in Hepatic Carcinoma
por: Tang, Xiaofeng, et al.
Publicado: (2020)

LncRNA GAS5 inhibits microglial M2 polarization and exacerbates demyelination
por: Sun, Dingya, et al.
Publicado: (2017)

Metformin reverses tamoxifen resistance through the lncRNA GAS5-medicated mTOR pathway in breast cancer
por: Jiang, Yiyan, et al.
Publicado: (2022)

Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma
por: Li, Yongsheng, et al.
Publicado: (2016)

LncRNA PACER is down-regulated in osteoarthritis and regulates chondrocyte apoptosis and lncRNA HOTAIR expression
por: Jiang, Mingwei, et al.
Publicado: (2019)

The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients
por: Ruan, Lingjuan, et al.
Publicado: (2018)

Assessment of prognostic role of a novel 7-lncRNA signature in HCC patients
por: Qu, Junchi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mhpd9j5ej5outa8j8l6hmgm8p5